Mani Menon
Henry Ford Hospital, Sorbonne Université, Henry Ford Health System, University School, Case Western Reserve University, New York University, Roswell Park Comprehensive Cancer Center, McGill University Health Centre, Wayne State University, Michigan United, Columbia University, Medanta The Medicity, Icahn School of Medicine at Mount Sinai, Michigan Institute of Urology, Mount Sinai Hospital, Mount Sinai Health System, Cranbrook Academy of Art
Papers
224
Total Citations
19,328
H-Index
71
About
Mani Menon stands as one of the most transformative figures in modern urological surgery, widely recognized as a pioneer in robotic-assisted radical prostatectomy (RARP) for the treatment of localized prostate cancer. As the founder of the Vattikuti Institute Prostatectomy program, Menon was instrumental in establishing the technical framework and clinical protocols that helped make robotic surgery the dominant approach in prostate cancer treatment worldwide. His landmark 2002 papers — comparing robot-assisted to traditional retropubic prostatectomy and laying out a structured laparoscopic and robotic program — earned nearly 1,000 combined citations and set the stage for a surgical revolution. His prolific 2012 series of systematic reviews and meta-analyses, collectively amassing over 2,500 citations, rigorously evaluated RARP's outcomes across urinary continence, potency, and oncological control, providing the evidence base that clinicians worldwide rely upon. Menon's research has consistently bridged innovation with outcomes-focused science, demonstrating not just that robotic surgery was feasible, but that it could meaningfully improve patient quality of life. With a body of work exceeding 5,700 citations across his top ten papers alone, his influence on urological oncology is both profound and enduring.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9Vattikuti Institute Prostatectomy: Technique390 citations · 2003
- 10Evolution of robotic radical prostatectomy375 citations · 2007